Difference between revisions of "Arsenic trioxide (Trisenox)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replace - "package insert<ref name="insert"></ref>." to "prescribing information.<ref name="insert"></ref>")
(updated content)
Line 1: Line 1:
 
==General information==
 
==General information==
Class/mechanism: Causes damage or degradation of PML-RAR alpha fusion protein, causes apoptosis-type changes in NB4 human promyelocytic leukemia cells in vitro.<ref name="insert">[http://www.drugbank.ca/system/fda_labels/DB01169.pdf?1265922813 Arsenic trioxide (Trisenox) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/arsenictrioxide.pdf Arsenic trioxide (Trisenox) package insert (locally hosted backup)]</ref>
+
Class/mechanism: Causes damage or degradation of PML-RAR alpha fusion protein, causes apoptosis-type changes in NB4 human promyelocytic leukemia cells in vitro.<ref name="insert">[http://www.drugbank.ca/system/fda_labels/DB01169.pdf?1265922813 Arsenic trioxide (Trisenox) package insert]</ref><ref>[[Media:Arsenictrioxide.pdf | Arsenic trioxide (Trisenox) package insert (locally hosted backup)]]</ref>
 
<br>Route: IV
 
<br>Route: IV
 
<br>Extravasation: [[irritant]]
 
<br>Extravasation: [[irritant]]
  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 +
 +
==Diseases for which it is used==
 +
*[[Acute myeloid leukemia]]
  
 
==Patient drug information==
 
==Patient drug information==
*[http://chemocare.com/bio/arsenic_trioxide.asp Arsenic trioxide (Trisenox) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/arsenic_trioxide.asp Arsenic trioxide (Trisenox) patient drug information (Chemocare)]</ref>
+
*[http://chemocare.com/chemotherapy/drug-info/arsenic-trioxide.aspx Arsenic trioxide (Trisenox) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/arsenic-trioxide.aspx Arsenic trioxide (Trisenox) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/arsenic-trioxide-patient-drug-information Arsenic trioxide (Trisenox) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/arsenic-trioxide-patient-drug-information Arsenic trioxide (Trisenox) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/arsenic-trioxide-patient-drug-information Arsenic trioxide (Trisenox) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/arsenic-trioxide-patient-drug-information Arsenic trioxide (Trisenox) patient drug information (UpToDate)]</ref>
  
 
==References==
 
==References==
 
<references/>
 
<references/>

Revision as of 15:24, 7 October 2012

General information

Class/mechanism: Causes damage or degradation of PML-RAR alpha fusion protein, causes apoptosis-type changes in NB4 human promyelocytic leukemia cells in vitro.[1][2]
Route: IV
Extravasation: irritant

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

References